Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

British Skin Foundation

If our patients are diverse, why are clinical trials so white?

Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue...

Blue Latitude Health

- PMLiVE

Mobile ethnography means no delays to the PoTS LIVE charity project

The team at Origins Insights are excited to introduce PoTS LIVE, our pro bono mobile ethnography project. Remarkably, the project marches on with its fieldwork phase even with the current...

Bedrock Healthcare Communications

- PMLiVE

Policy and public health: all the decisions we can’t see

January was a bad month for healthcare in China

What gets on your nerves?

COUCH Health

- PMLiVE

New typhoid vaccine could transform fight against the infection

Could help to prevent millions of cases worldwide

- PMLiVE

£1 billion cuts to public health must be reversed, say charities

Cuts already having impact

- PMLiVE

Havas Lynx poem for charity has women’s interests at heart

Highlights overlooked cardiovascular risks

Putting our mission into practice: Porterhouse Medical’s charity round-up 2018 – 2019

As part of our mission to help improve people’s lives, each year Porterhouse Medical selects a local charity partner to support with fundraising events, using our communications expertise to raise...

Porterhouse Medical Group

- PMLiVE

NICE U-turn sees Opdivo backed as adjuvant therapy for skin cancer

But it is only available via the CDF for now

World AIDS Day 2018: Fighting the stigma surrounding HIV

To support World AIDS Day 2018 and to help tackle the stigma surrounding the condition, Porterhouse Medical explores the misconceptions surrounding HIV/AIDS.

Porterhouse Medical Group

Barber shops provide a short cut to BP reduction

As well as a haircut, barbers can shave millimetres off men's blood pressure

Life Healthcare Communications

Sanofi reception

Sanofi’s latecomer PD-1 gets date for FDA verdict

While Keytruda extends its lead, Sanofi makes a late bid to enter PD-1 space

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links